- Home
- ADSE vs HQL Comparison
ADSE vs HQL Comparison
Compare ADSE & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADSE | HQL |
|---|---|---|
| Founded | 1980 | 1992 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 577.8M | 510.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ADSE | HQL |
|---|---|---|
| Price | $12.27 | $16.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.9K | ★ 120.9K |
| Earning Date | 12-23-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $53,275,396.00 | N/A |
| Revenue This Year | $219.58 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.08 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.89 | $11.34 |
| 52 Week High | $16.35 | $14.37 |
Technical Indicators
Market Signals| Indicator | ADSE | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 67.24 | 50.30 |
| Support Level | $9.76 | $16.35 |
| Resistance Level | $10.68 | $17.70 |
| Average True Range (ATR) | 0.68 | 0.39 |
| MACD | 0.24 | -0.02 |
| Stochastic Oscillator | 89.47 | 40.74 |
Price Performance
Historical ComparisonAbout ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.